The U.S. Food and Drug Administration has recently revised vaccine review guidelines, deciding not to entertain emergency use applications. Instead, the agency is now contemplating review only through the full approval process route, CvAC chances approval by EMA(European eqv to US EUA) is great due to shortage of vaccine in Europe.